- Home
- STOK vs KDK Comparison
STOK vs KDK Comparison
Compare STOK & KDK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- KDK
- Stock Information
- Founded
- STOK 2014
- KDK 2018
- Country
- STOK United States
- KDK United States
- Employees
- STOK N/A
- KDK N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- KDK EDP Services
- Sector
- STOK Health Care
- KDK Technology
- Exchange
- STOK Nasdaq
- KDK Nasdaq
- Market Cap
- STOK 1.3B
- KDK 1.3B
- IPO Year
- STOK 2019
- KDK N/A
- Fundamental
- Price
- STOK $23.19
- KDK $7.76
- Analyst Decision
- STOK Strong Buy
- KDK Strong Buy
- Analyst Count
- STOK 9
- KDK 3
- Target Price
- STOK $31.00
- KDK $16.17
- AVG Volume (30 Days)
- STOK 1.4M
- KDK 737.2K
- Earning Date
- STOK 11-04-2025
- KDK 11-12-2025
- Dividend Yield
- STOK N/A
- KDK N/A
- EPS Growth
- STOK N/A
- KDK N/A
- EPS
- STOK 0.68
- KDK N/A
- Revenue
- STOK $205,632,000.00
- KDK $16,079,999.00
- Revenue This Year
- STOK $416.54
- KDK N/A
- Revenue Next Year
- STOK N/A
- KDK N/A
- P/E Ratio
- STOK $33.39
- KDK N/A
- Revenue Growth
- STOK 1128.17
- KDK N/A
- 52 Week Low
- STOK $5.35
- KDK $5.77
- 52 Week High
- STOK $38.69
- KDK $10.48
- Technical
- Relative Strength Index (RSI)
- STOK 33.50
- KDK N/A
- Support Level
- STOK $20.32
- KDK N/A
- Resistance Level
- STOK $33.88
- KDK N/A
- Average True Range (ATR)
- STOK 2.07
- KDK 0.00
- MACD
- STOK -1.56
- KDK 0.00
- Stochastic Oscillator
- STOK 18.78
- KDK 0.00
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
About KDK Kodiak AI Inc. Common Stock
Kodiak AI Inc is engaged in the commercial trucking industry and the public sector, based on AI-powered autonomous vehicle technology.